iTeos Therapeutics is a publicly-held (NASDAQ: ITOS), clinical-stage biopharmaceutical company dedicated to extending and improving the lives of cancer patients by designing and developing next generation immunotherapies.
Based in Gosselies, Belgium and Cambridge, MA, iTeos Therapeutics was founded out of the Ludwig Institute for Cancer Research (LICR) and the de Duve Institute (UCLouvain) in 2011.
In March 2020, the Company completed a $125 million Series B2 financing, and in July 2020, we completed our IPO raising over $230million of gross proceeds. In June 2021, iTeos entered into a transformative $2.145 billion co-development and co-commercialization agreement with GSK for EOS-448, iTeos’s anti-TIGITmonoclonal antibody. As a well-capitalized biotech company iTeos is positioned to continue to develop our clinical pipeline and maintain our investments in our discovery research team to leverage our fantastic science to improve the lives of cancer patients.
For more information, please visit www.iteostherapeutics.com.
iTeos Therapeutics is now a world-class biotech in cancer immunotherapy. To carry on its growth, expand its pipeline and reinforce its team, iTeos Therapeutics is looking for a Research Assistant - Tumor immunology.
Within its Translational Medicine Department, iTeos is looking for a highly motivated and skilled Research Assistant that will work in close collaboration with Institute Jules Bordet. The successful candidate will unveil the complexity of the tumor microenvironement and its immunosuppressive condition with a focus on our targets and their specific pathways. In this role, the candidate will work independently and as part of a team to set-up multiplex IHC panels and generate robust mIHC data packages, helping to guide decision making and timely progression of our programs. He/she will also participate to the collection, processing and analysis of biological material from cancer patients. The labs (iTeos and Institut Jules Bordet) are equipped with state-of-the art technologies to study models of immunology and cancer.They are also equipped with an automated platform for IHC and mIHC to study complexity of cancer tissues.
This is an exciting opportunity for a talented Research Assistant eager to contribute in a meaningful way to the development of innovative IO drugs for cancer patients.
This position requires to work around 60% at Institut Jules Bordet site (Molecular Immunology Unit, Willard-Gallo lab, Brussels) and 40% at iTeos Belgium site (Gosselies).
Please send your CV together with an adapted cover letter to the following address : email@example.com.
Please, mention the reference RA-TI-TM in the mail object. Your application and related information will remain strictly confidential.
For our recruitments in Belgium, we closely collaborate with a Recruitment & Selection company, PaHRtners. Your application will be automatically forwarded to them.
We, together with PaHRtners, will keep all your data confidential (GDPR compliant approach).